Literature DB >> 20101130

Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?

Joyce S B Koh1, Seo Kiat Goh, Meng Ai Png, Ernest B K Kwek, Tet Sen Howe.   

Abstract

OBJECTIVE: Lateral cortical stress reactions have been documented to precede femoral insufficiency fractures after long-term bisphosphonate therapy. We studied the natural history of femoral stress lesions associated with long-term bisphosphonate therapy. DESIGN AND
SETTING: A retrospective clinical and radiologic review of all patients with radiologically documented femoral stress lesions associated with bisphosphonate therapy was carried out in a tertiary center involved with geriatric trauma care. PATIENTS: Of 1463 geriatric hip fractures occurring from May 1, 2004, to July 31, 2008, 33 were of a distinct metaphyseal-diaphyseal configuration. Thirty-two were on prior bisphosphonate therapy. Sixteen femurs showed a lateral cortical thickening either on prefracture radiographs (four femurs) or on radiographs of the contralateral femur (12 femurs). MAIN OUTCOME MEASURES: Features that predispose to complete stress fractures were determined. The intact femurs were followed up for symptomatic and radiologic progression and occurrence of new lesions.
RESULTS: All four cases that fractured had a "dreaded black line" in the lesion, whereas only 1 of 12 patients had this fracture in femurs which remained intact (100% versus 8.3%, P = 0.003). All patients who fractured reported thigh discomfort over 1 month (range, 0.1-9.0 months; standard deviation, 4.0 months), whereas three of 12 patients who did not fracture reported thigh discomfort (100% versus 25%, P = 0.019). In the remaining patients, eight patients were asymptomatic, two patients had reduced symptoms, and one patient had persistent thigh pain at 23.0 months (range, 5-35 months; standard deviation, 10.2 months). One patient was too demented for symptomatic assessment. No patient developed a new lesion. Radiologic stabilization of the lateral cortical thickening was evident on follow-up radiographs.
CONCLUSION: Cortical stress reactions associated with prolonged antiresorptive therapy, in the presence of pain and the "dreaded black line," have an increased risk for complete stress fractures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101130     DOI: 10.1097/BOT.0b013e3181b6499b

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  42 in total

1.  Bisphosphonate-associated femur fractures have high complication rates with operative fixation.

Authors:  Mark L Prasarn; Jaimo Ahn; David L Helfet; Joseph M Lane; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2012-06-06       Impact factor: 4.176

2.  Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur.

Authors:  Joyce S B Koh; Alvin C M Ng; Meng Ai Png; Tet Sen Howe
Journal:  Clin Orthop Relat Res       Date:  2011-12       Impact factor: 4.176

Review 3.  Subtrochanteric femoral insufficiency fractures related to the use of long-term bisphosphonates: a pictorial review.

Authors:  Nanda Venkatanarasimha; Gemma Miles; Priya Suresh
Journal:  Emerg Radiol       Date:  2010-07-20

4.  Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy.

Authors:  P Chandra Mohan; Tet Sen Howe; Joyce S B Koh; Meng Ai Png
Journal:  Eur Radiol       Date:  2012-07-20       Impact factor: 5.315

5.  [Biphosphonate-induced femoral stress fractures : A new problem and knowledge so far - case report].

Authors:  R Lenz; M Ellenrieder; R Skripitz; R Bader; C Pautke; W Mittelmeier; T Tischer
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

Review 6.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

7.  Prodromal Symptoms in Patients with Bisphosphonate-Associated Atypical Fractures of the Femur.

Authors:  Mohammad Kharazmi; Karl Michaëlsson; Pär Hallberg
Journal:  J Bone Miner Metab       Date:  2014-10-16       Impact factor: 2.626

8.  Bisphosphonate associated femoral stress fracture distal to an orthopaedic implant: They are predictable!

Authors:  Gunasekaran Kumar; Anoop C Dhamangaonkar
Journal:  J Clin Orthop Trauma       Date:  2019-01-11

9.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 10.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.